[ad_1]
Innsbruck – A research project by the Tirol Kliniken and the Innsbruck Medical University aims to use an online survey to reach up to a quarter of the corona infected people who have recovered, thus generating new scientific findings about the course of the disease and its long-term consequences. “The goal is to illuminate all aspects of the disease,” emphasized Günter Weiss, director of the University Clinic of Internal Medicine II.
We already know quite a bit about Corona, Weiss added at a press conference in Innsbruck on Wednesday. However, scientific data is still needed, especially regarding the long-term and long-term consequences of a past corona disease. “We want to know exactly what these consequences are like,” emphasized the infectologist.
Focus on performance and health after illness.
Among other things, one is interested in the survey on whether performance and health are the same as before after surviving the infection, said Judith Löffler-Ragg, senior physician at the pulmonary ambulatory clinic at the University Clinic of Internal Medicine II. . “The question of whether most patients are really well after two weeks is also key,” said the leader of the research project. In addition, general conclusions about the different courses of the disease are expected, he added.
The latest news
They also want to focus on “neurological manifestations,” explained Raimund Helbok, a senior physician in the field of intensive neurological medicine at the University Clinic of Neurology. “This includes, for example, an olfactory disorder that occurs in corona-infected people without a cold,” he explained. One wants to clarify the percentage of this disorder that occurs in infected people, he said regarding the Covid-19 study that begins today.
In general, after the study, in which all people 16 years of age or older who have experienced a corona infection can participate in the study, they want to know, for example, if a “mild or severe course” can be expected in different patient groups in the future, Weiss said. It is also expected to know which therapies make sense at what time and a possible more precise delineation of high-risk patients, the expert gave an idea of the expectations of the interdisciplinary team behind the study. (APA)
